Discontinuation report AGRYLIN
Report ID | 210182 |
Drug Identification Number | 02236859 |
Brand name | AGRYLIN |
Common or Proper name | Anagrelide hydrochloride capsules |
Company Name | TAKEDA CANADA INC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | ANAGRELIDE |
Strength(s) | 0.5MG |
Dosage form(s) | CAPSULE |
Route of administration | ORAL ORAL |
Packaging size | Bottles of 100 capsules |
ATC code | L01XX |
ATC description | OTHER ANTINEOPLASTIC AGENTS |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | 2024-02-28 |
Actual discontinuation date | 2024-02-29 |
Remaining supply date | 2024-06-30 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | Remaining supply expires JUNE 2024 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 22 ADELAIDE STREET WEST TORONTO, ONTARIO CANADA M5H 4E3 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v5 | 2024-03-01 | French | Compare |
v4 | 2024-03-01 | English | Compare |
v3 | 2023-11-14 | French | Compare |
v2 | 2023-11-14 | English | Compare |
v1 | 2023-11-14 | English | Compare |
Showing 1 to 5 of 5